Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-019913-12Phase 4Active
Phase 4, randomised trial of sterofundin in None (2 arms), sponsored by Istituto Giannina Gaslini. Primary endpoint: Change in plasma sodium concentration. Started Apr 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-019913-12.